Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

The pharmacology and therapeutic applications of monoclonal antibodies.

Castelli MS, McGonigle P, Hornby PJ.

Pharmacol Res Perspect. 2019 Dec;7(6):e00535. doi: 10.1002/prp2.535. Review.

2.

Overview of Transgenic Mouse Models for Alzheimer's Disease.

Myers A, McGonigle P.

Curr Protoc Neurosci. 2019 Sep;89(1):e81. doi: 10.1002/cpns.81.

PMID:
31532917
3.

Prostacyclin and EMT Pathway Markers for Monitoring Response to Lung Cancer Chemoprevention.

New ML, White CM, McGonigle P, McArthur DG, Dwyer-Nield LD, Merrick DT, Keith RL, Tennis MA.

Cancer Prev Res (Phila). 2018 Oct;11(10):643-654. doi: 10.1158/1940-6207.CAPR-18-0052. Epub 2018 Jul 25.

4.

Graduate Education in Pharmacology: Addressing the need for specialized training for pharmaceutical and biotechnology careers.

Barrett JE, McGonigle P, Clark JE.

Pharmacol Res. 2016 Nov;113(Pt A):327-331. doi: 10.1016/j.phrs.2016.08.030. Epub 2016 Aug 31. No abstract available.

PMID:
27590782
5.

Locus Coeruleus, norepinephrine and Aβ peptides in Alzheimer's disease.

Ross JA, McGonigle P, Van Bockstaele EJ.

Neurobiol Stress. 2015;2:73-84.

6.

A store-operated calcium channel inhibitor attenuates collagen-induced arthritis.

Gao XH, Gao R, Tian YZ, McGonigle P, Barrett JE, Dai Y, Hu H.

Br J Pharmacol. 2015 Jun;172(12):2991-3002. doi: 10.1111/bph.13104. Epub 2015 Mar 27.

7.

Targeting the Neuropeptide Y System in Stress-related Psychiatric Disorders.

Enman NM, Sabban EL, McGonigle P, Van Bockstaele EJ.

Neurobiol Stress. 2015 Jan 1;1:33-43.

8.

Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease.

Wyrofsky R, McGonigle P, Van Bockstaele EJ.

Expert Opin Drug Discov. 2015 Jan;10(1):17-36. doi: 10.1517/17460441.2014.966680. Epub 2014 Dec 9. Review.

9.

Animal models of human disease: challenges in enabling translation.

McGonigle P, Ruggeri B.

Biochem Pharmacol. 2014 Jan 1;87(1):162-71. doi: 10.1016/j.bcp.2013.08.006. Epub 2013 Aug 14. Review.

PMID:
23954708
10.

Animal models of CNS disorders.

McGonigle P.

Biochem Pharmacol. 2014 Jan 1;87(1):140-9. doi: 10.1016/j.bcp.2013.06.016. Epub 2013 Jun 26. Review.

PMID:
23811310
11.

Peptide therapeutics for CNS indications.

McGonigle P.

Biochem Pharmacol. 2012 Mar 1;83(5):559-66. doi: 10.1016/j.bcp.2011.10.014. Epub 2011 Oct 25. Review.

PMID:
22051078
12.

Structure-based design leads to the identification of lithium mimetics that block mania-like effects in rodents. possible new GSK-3beta therapies for bipolar disorders.

Kozikowski AP, Gaisina IN, Yuan H, Petukhov PA, Blond SY, Fedolak A, Caldarone B, McGonigle P.

J Am Chem Soc. 2007 Jul 4;129(26):8328-32. Epub 2007 Jun 7.

PMID:
17552518
13.

Spatiotemporal evidence of apoptosis-mediated ischemic injury in organotypic hippocampal slice cultures.

Cho S, Liu D, Fairman D, Li P, Jenkins L, McGonigle P, Wood A.

Neurochem Int. 2004 Jul;45(1):117-27.

PMID:
15082229
14.

Nanoprobe NMR spectroscopy and in vivo microdialysis: new analytical methods to study brain neurochemistry.

Khandelwal P, Beyer CE, Lin Q, McGonigle P, Schechter LE, Bach AC 2nd.

J Neurosci Methods. 2004 Feb 15;133(1-2):181-9.

PMID:
14757359
15.

Serotonin mechanisms in heart valve disease II: the 5-HT2 receptor and its signaling pathway in aortic valve interstitial cells.

Xu J, Jian B, Chu R, Lu Z, Li Q, Dunlop J, Rosenzweig-Lipson S, McGonigle P, Levy RJ, Liang B.

Am J Pathol. 2002 Dec;161(6):2209-18.

16.

Differential regulation of dopamine D2 and D3 receptors by chronic drug treatments.

Stanwood GD, Lucki I, McGonigle P.

J Pharmacol Exp Ther. 2000 Dec;295(3):1232-40.

PMID:
11082460
17.
18.

Physiological and anatomical correlates of the human dentate gyrus: consequences or causes of epilepsy.

Masukawa LM, Burdette LJ, McGonigle P, Wang H, O'Connor W, Sperling MR, O'Connor MJ, Uruno K.

Adv Neurol. 1999;79:781-94. Review.

PMID:
10514863
19.

Differential effects of three acute stressors on the serotonin 5-HT1A receptor system in rat brain.

Raghupathi RK, McGonigle P.

Neuroendocrinology. 1997 Apr;65(4):246-58.

PMID:
9142996
20.

Ontogeny of dopamine D3 receptors in the nucleus accumbens of the rat.

Stanwood GD, McElligot S, Lu L, McGonigle P.

Neurosci Lett. 1997 Feb 14;223(1):13-6.

PMID:
9058411
21.

Mossy fiber reorganization and its possible physiological consequences in the dentate gyrus of epileptic humans.

Masukawa LM, O'Connor WM, Burdette LJ, McGonigle P, Sperling MR, O'Connor MJ, Uruno K.

Adv Neurol. 1997;72:53-68. Review.

PMID:
8993684
22.

Regional variability in changes in 5-HT2A receptor mRNA levels in rat brain following irreversible inactivation with EEDQ.

Raghupathi RK, Artymyshyn R, McGonigle P.

Brain Res Mol Brain Res. 1996 Jul;39(1-2):198-206.

PMID:
8804728
23.

Time-course of recovery of 5-HT1A receptors and changes in 5-HT1A receptor mRNA after irreversible inactivation with EEDQ.

Raghupathi RK, Brousseau DA, McGonigle P.

Brain Res Mol Brain Res. 1996 Jun;38(2):233-42.

PMID:
8793111
24.

Changes in behavioral sensitivity to SKF-38393 and quinpirole following withdrawal from continuous cocaine administration in rats.

Neisewander JL, Lucki I, McGonigle P.

Pharmacol Biochem Behav. 1996 Apr;53(4):935-42.

PMID:
8801600
25.

Pharmacological and immunological characterization of N-methyl-D-aspartate receptors in human NT2-N neurons.

Munir M, Lu L, Wang YH, Luo J, Wolfe BB, McGonigle P.

J Pharmacol Exp Ther. 1996 Feb;276(2):819-28.

PMID:
8632355
26.

Excitotoxic cell death and delayed rescue in human neurons derived from NT2 cells.

Munir M, Lu L, Mcgonigle P.

J Neurosci. 1995 Dec;15(12):7847-60.

27.

Longitudinal variation in cell density and mossy fiber reorganization in the dentate gyrus from temporal lobe epileptic patients.

Masukawa LM, O'Connor WM, Lynott J, Burdette LJ, Uruno K, McGonigle P, O'Connor MJ.

Brain Res. 1995 Apr 24;678(1-2):65-75.

PMID:
7620900
28.
29.

Variations in the behavioral responses to apomorphine in different strains of rats.

Essman WD, Luedtke RR, McGonigle P, Lucky I.

Behav Pharmacol. 1995 Jan;6(1):4-15.

PMID:
11224306
30.

Polyamine effects on the NMDA receptor in human brain.

Subramaniam S, O'Connor MJ, Masukawa LM, McGonigle P.

Exp Neurol. 1994 Dec;130(2):323-30.

PMID:
7867761
31.
33.

Thyroid and thyroxine effects on adrenoreceptors in relation to circadian activity.

Vessotskie JM, McGonigle P, Molthen RC, McEachron DL.

Pharmacol Biochem Behav. 1993 Sep;46(1):251-7.

PMID:
8255919
34.

Polyamines modulate the neurotoxic effects of NMDA in vivo.

Munir M, Subramaniam S, McGonigle P.

Brain Res. 1993 Jul 9;616(1-2):163-70.

PMID:
8358608
35.

Regional heterogeneity of polyamine effects on the N-methyl-D-aspartate receptor in rat brain.

Subramaniam S, McGonigle P.

J Neurochem. 1993 Jun;60(6):2276-84.

PMID:
8492131
36.
37.

Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.

Subramaniam S, Lucki I, McGonigle P.

Brain Res. 1992 Feb 7;571(2):313-22.

PMID:
1351781
38.
39.

Behavioral and neurochemical effects of chronic administration of reserpine and SKF-38393 in rats.

Neisewander JL, Lucki I, McGonigle P.

J Pharmacol Exp Ther. 1991 May;257(2):850-60.

PMID:
2033524
41.

Pneumothorax: treatment by small-lumen catheter aspiration.

Markos J, McGonigle P, Phillips MJ.

Aust N Z J Med. 1990 Dec;20(6):775-81.

PMID:
2291726
42.
43.

Effects of chronic treatment with selective and nonselective antagonists on the subtypes of dopamine receptors.

McGonigle P, Boyson SJ, Reuter S, Molinoff PB.

Synapse. 1989;3(1):74-82.

PMID:
2521960
44.

[3H]SCH 23390 labels both dopamine-1 and 5-hydroxytryptamine1c receptors in the choroid plexus.

Nicklaus KJ, McGonigle P, Molinoff PB.

J Pharmacol Exp Ther. 1988 Oct;247(1):343-8.

PMID:
2971798
45.

Comparison of 125I-SCH 23982 and [3H]SCH 23390 as ligands for the D-1 dopamine receptor.

Manik CP, Molinoff PB, McGonigle P.

J Neurochem. 1988 Aug;51(2):391-7.

PMID:
3292702
46.

Characterization of binding sites for 3H-spiroperidol in human retina.

McGonigle P, Wax MB, Molinoff PB.

Invest Ophthalmol Vis Sci. 1988 May;29(5):687-94.

PMID:
2452802
47.

Effects of chronic administration of neuroleptic and anticholinergic agents on densities of D2 dopamine and muscarinic cholinergic receptors in rat striatum.

Boyson SJ, McGonigle P, Luthin GR, Wolfe BB, Molinoff PB.

J Pharmacol Exp Ther. 1988 Mar;244(3):987-93.

PMID:
2908050
48.
49.

Characterization of D-2 dopamine receptors in a tumor of the rat anterior pituitary gland.

Lin C, McGonigle P, Molinoff PB.

J Pharmacol Exp Ther. 1987 Sep;242(3):950-6.

PMID:
2958621
50.

Evaluation of models for analysis of radioligand binding data.

Abramson SN, McGonigle P, Molinoff PB.

Mol Pharmacol. 1987 Jan;31(1):103-11.

PMID:
3027522

Supplemental Content

Loading ...
Support Center